Switch to:
More From Other Websites
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Feb 21 2017
8:46 am CEL-SCI Corp presents data at LEAPS Rheumatoid Arthritis therapeutic vaccine at Madridge's... Feb 21 2017
CEL-SCI Scientist Presents New Findings for Rheumatoid Arthritis Treatment Vaccine at Conference Feb 21 2017
CEL-SCI Announces $1.0 Million Registered Direct Offering Feb 17 2017
CEL SCI CORP Financials Feb 15 2017
CEL SCI CORP Files SEC form 8-K, Other Events Feb 13 2017
Cel-Sci posts 1Q profit Feb 09 2017
Cel-Sci posts 1Q profit Feb 09 2017
CEL-SCI Corporation Reports First Quarter Fiscal 2017 Financial Results Feb 09 2017
CEL SCI CORP Files SEC form 10-Q, Quarterly Report Feb 09 2017
CEL SCI CORP Files SEC form 8-K, Other Events Dec 22 2016
NEW STORY CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 21 2016
CEL-SCI Announces Closing of Public Offering and Receives Audit Opinion with Going Concern... Dec 20 2016
Cel-Sci reports 4Q loss Dec 14 2016
Cel-Sci reports 4Q loss Dec 14 2016
CEL-SCI Reports Fiscal 2016 Financial Results and Clinical & Corporate Developments Dec 14 2016
CEL SCI CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule... Dec 14 2016
CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan Dec 09 2016
CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Dec 02 2016
CEL-SCI Announces Pricing of $4.25 Million Public Offering of Common Stock and Warrants Dec 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK